161 related articles for article (PubMed ID: 2548961)
1. Role of angiotensin converting enzyme and other peptidases in in vivo metabolism of kinins.
Ishida H; Scicli AG; Carretero OA
Hypertension; 1989 Sep; 14(3):322-7. PubMed ID: 2548961
[TBL] [Abstract][Full Text] [Related]
2. Contributions of various rat plasma peptidases to kinin hydrolysis.
Ishida H; Scicli AG; Carretero OA
J Pharmacol Exp Ther; 1989 Dec; 251(3):817-20. PubMed ID: 2557417
[TBL] [Abstract][Full Text] [Related]
3. Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivo.
Ura N; Carretero OA; Erdös EG
Kidney Int; 1987 Oct; 32(4):507-13. PubMed ID: 2828746
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary kinin metabolism and conversion of angiotensin I in spontaneously hypertensive rats.
Pesquero JB; Boschcov P; Lindsey CJ; Paiva AC
J Hypertens; 1992 Dec; 10(12):1479-84. PubMed ID: 1363433
[TBL] [Abstract][Full Text] [Related]
5. Effect of a kinin antagonist on the acute antihypertensive activity of enalaprilat in severe hypertension.
Carbonell LF; Carretero OA; Stewart JM; Scicli AG
Hypertension; 1988 Mar; 11(3):239-43. PubMed ID: 2895070
[TBL] [Abstract][Full Text] [Related]
6. Role of kinins in the renal response to enalaprilat in normotensive and hypertensive rats.
Fitzgibbon WR; Jaffa AA; Mayfield RK; Ploth DW
Hypertension; 1996 Feb; 27(2):235-44. PubMed ID: 8567046
[TBL] [Abstract][Full Text] [Related]
7. Serum interspecies differences in metabolic pathways of bradykinin and [des-Arg9]BK: influence of enalaprilat.
Décarie A; Raymond P; Gervais N; Couture R; Adam A
Am J Physiol; 1996 Oct; 271(4 Pt 2):H1340-7. PubMed ID: 8897926
[TBL] [Abstract][Full Text] [Related]
8. Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels.
Johnston CI; Clappison BH; Anderson WP; Yasujima M
Am J Cardiol; 1982 Apr; 49(6):1401-4. PubMed ID: 6122371
[TBL] [Abstract][Full Text] [Related]
9. Kinin metabolism in human nasal secretions during experimentally induced allergic rhinitis.
Proud D; Baumgarten CR; Naclerio RM; Ward PE
J Immunol; 1987 Jan; 138(2):428-34. PubMed ID: 2878955
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin converting enzyme (ACE) inhibitors and kinin metabolism: evidence that ACE inhibitors may inhibit a kininase other than ACE.
Campbell DJ
Clin Exp Pharmacol Physiol; 1995 Dec; 22(12):903-11. PubMed ID: 8846511
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of bradykinin agonists and antagonists by plasma aminopeptidase P.
Ward PE; Chow A; Drapeau G
Biochem Pharmacol; 1991 Jul; 42(4):721-7. PubMed ID: 1651078
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC
Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin and bradykinin metabolism by peptidases identified in skeletal muscle.
Ward PE; Russell JS; Vaghy PL
Peptides; 1995; 16(6):1073-8. PubMed ID: 8532591
[TBL] [Abstract][Full Text] [Related]
14. Vascular catabolism of bradykinin in the isolated perfused rat kidney.
Bagaté K; Develioglu L; Grima M; De Jong W; Simmons WH; Imbs JL; Barthelmebs M
Eur J Pharmacol; 2000 Nov; 407(3):317-25. PubMed ID: 11068029
[TBL] [Abstract][Full Text] [Related]
15. The role of nitric oxide, adrenergic activation and kinin-degradation in blood pressure homeostasis following an acute kinin-induced hypotension.
Bjørnstad-Ostensen A; Berg T
Br J Pharmacol; 1994 Dec; 113(4):1567-73. PubMed ID: 7889314
[TBL] [Abstract][Full Text] [Related]
16. Bradykinin degrading activity in cultured human endothelial cells.
Graf K; Gräfe M; Auch-Schwelk W; Baumgarten CR; Bossaller C; Fleck E
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S16-20. PubMed ID: 1282624
[TBL] [Abstract][Full Text] [Related]
17. Degradation pathway of kinins in tumor ascites and inhibition by kininase inhibitors: analysis by HPLC.
Matsumura Y; Maeda H; Kato H
Agents Actions; 1990 Mar; 29(3-4):172-80. PubMed ID: 2160186
[TBL] [Abstract][Full Text] [Related]
18. Contribution of angiotensin-converting enzyme to the cardiac metabolism of bradykinin: an interspecies study.
Blais C; Drapeau G; Raymond P; Lamontagne D; Gervais N; Venneman I; Adam A
Am J Physiol; 1997 Nov; 273(5):H2263-71. PubMed ID: 9374762
[TBL] [Abstract][Full Text] [Related]
19. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
Vora JP; Oyama TT; Thompson MM; Anderson S
Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
[TBL] [Abstract][Full Text] [Related]
20. Type 2 bradykinin-receptor antagonism does not modify kinin or angiotensin peptide levels.
Campbell DJ; Kladis A; Briscoe TA; Zhuo J
Hypertension; 1999 May; 33(5):1233-6. PubMed ID: 10334817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
